Low levels of NAD+ trigger the reactive oxygen species (ROS)-dependent degradation of 15-hydroxyprostaglandin dehydrogenase, an identified tumor suppressor enzyme, thereby advancing the cellular epithelial–mesenchymal transition (EMT), which is considered the driver of tumor initiation and metastasis [12]. This evidence concerns the gene HPGD and neoplasm.